According to Millennium Research Group, the North American facial injectables market, comprising botulinum toxin and dermal fillers sold in the US and Canada, will continue to show strong growth for the next five years, reaching a total value of more than $1.7 billion by 2017. Millennium Research Group's North American Markets for Facial Injectables 2013 report includes unit, average selling price, and revenue information, along with market drivers and limiters and competitive landscape for botulinum and dermal fillers sold in North America.